As of December 2024 Vertex Pharmaceuticals has 257.70M shares outstanding, a increase of 0.62% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 257.70M | 0.62% |
2022 | 256.10M | -0.62% |
2021 | 257.70M | -0.82% |
2020 | 259.84M | - |